These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6797226)

  • 41. Stupor and fast activity on electroencephalography in a child treated with valproate.
    Mastrangelo M; Mariani R; Spalice A; Rocchi V; Iannetti P
    Pediatr Neurol; 2009 Jul; 41(1):53-6. PubMed ID: 19520277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sodium valproate reassessed.
    Drug Ther Bull; 1981 Nov; 19(24):93-5. PubMed ID: 6793342
    [No Abstract]   [Full Text] [Related]  

  • 43. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
    Boggs JG; Preis K
    Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children.
    Aycicek A; Iscan A
    Eur Neurol; 2007; 57(2):65-9. PubMed ID: 17179706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Valproic acid and sodium valproate approved for use in epilepsy.
    FDA Drug Bull; 1978; 8(2):14-5. PubMed ID: 344120
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of valproic acid on hepatic functions.
    Maheshwari MC; Tandon RK
    J Assoc Physicians India; 1982 Aug; 30(8):529-31. PubMed ID: 6820370
    [No Abstract]   [Full Text] [Related]  

  • 47. Video-EEG in syncopal attack due to ocular compression in an adolescent mistreated for epilepsy.
    Gelisse P; Serafini A; Davy JM; Balbe M; Coubes P; Crespel A
    Epileptic Disord; 2007 Jun; 9(2):174-8. PubMed ID: 17525029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study].
    Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V
    Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058
    [No Abstract]   [Full Text] [Related]  

  • 49. Spectral analysis of the EEG in children during the introduction of antiepileptic therapy with valproic acid.
    Benninger C; Matthis P; Scheffner D
    Neuropsychobiology; 1985; 13(1-2):93-6. PubMed ID: 3929157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proceedings: Sodium valproate (Epilim) in the treatment of intractable epilepsy, including some observations on blood levels.
    Scott DF; Lloyd MH; France M; Hamilton C; Cohne RD
    Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):429. PubMed ID: 51736
    [No Abstract]   [Full Text] [Related]  

  • 51. Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin.
    Hayashi T; Yoshida S; Yoshinaga A; Ohno R; Ishii N; Yamada T
    Scand J Urol Nephrol; 2005; 39(5):431-2. PubMed ID: 16257847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transient decrease in serum albumin concentrations in epileptic children treated with sodium valproate monotherapy.
    Attilakos A; Voudris KA; Katsarou E; Prassouli A; Mastroyianni S; Garoufi A
    Clin Neuropharmacol; 2007; 30(3):145-9. PubMed ID: 17545749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Problems of therapeutic service in valproate therapy].
    Köhler E; Quednow B; Walther H
    Z Arztl Fortbild (Jena); 1980 Aug; 74(15):694-7. PubMed ID: 6777996
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of valproic acid on hearing in epileptic patients.
    Incecik F; Akoglu E; Sangün O; Melek I; Duman T
    Int J Pediatr Otorhinolaryngol; 2007 Apr; 71(4):611-4. PubMed ID: 17270285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy.
    Shakir RA; Johnson RH; Lambie DG; Melville ID; Nanda RN
    Epilepsia; 1981 Feb; 22(1):27-33. PubMed ID: 6781888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy.
    Jakovljevic MB; Jankovic SM; Jankovic SV; Todorovic N
    Epilepsy Res; 2008 Aug; 80(2-3):180-3. PubMed ID: 18495431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Natrium valproate, antiepileptic effect--serum concentration. A controlled study].
    Gram L; Flachs H; Würtz-Jørgensen A; Parnas J; Andersen B
    Ugeskr Laeger; 1979 Jul; 141(27):1833-7. PubMed ID: 382557
    [No Abstract]   [Full Text] [Related]  

  • 58. Valproate monotherapy in the treatment of epilepsy.
    Am J Med; 1988 Jan; 84(1A):1-41. PubMed ID: 3146218
    [No Abstract]   [Full Text] [Related]  

  • 59. [Studies on the therapeutic scope of valproic acid].
    Schulz HU; Fröscher W; Gugler R; Eichelbaum M
    Med Welt; 1979 Jan; 30(2):59-61. PubMed ID: 364248
    [No Abstract]   [Full Text] [Related]  

  • 60. [Stuporous state in an epileptic treated with sodium valproate. Diagnostic problems].
    Milandre L; Rey M; Boudouresques G; Farnarier G; Poncet M
    Acta Neurol Belg; 1987; 87(2):70-5. PubMed ID: 3107333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.